Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis

1.

Aghi MK, Carter BS, Cosgrove GR et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60 (discussion 60)

PubMed  Google Scholar 

2.

Backer-Grondahl T, Moen BH, Torp SH (2012) The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 5:231–242

PubMed  PubMed Central  Google Scholar 

3.

Balduzzi S, Rucker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153–160

PubMed  Google Scholar 

4.

Banan R, Abbetmeier-Basse M, Hong B et al (2021) The prognostic significance of clinicopathological features in meningiomas: microscopic brain invasion can predict patient outcome in otherwise benign meningiomas. Neuropathol Appl Neurobiol 47:724–735

PubMed  Google Scholar 

5.

Barresi V, Lionti S, Caliri S et al (2018) Histopathological features to define atypical meningioma: what does really matter for prognosis? Brain Tumor Pathol 35:168–180

PubMed  Google Scholar 

6.

Barrett OC, Hackney JR, Mcdonald AM et al (2019) Pathologic predictors of local recurrence in atypical meningiomas following gross total resection. Int J Radiat Oncol Biol Phys 103:453–459

PubMed  Google Scholar 

7.

Baumgarten P, Gessler F, Schittenhelm J et al (2016) Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 132:479–481

PubMed  Google Scholar 

8.

Biczok A, Jungk C, Egensperger R et al (2019) Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol 145:469–477

CAS  PubMed  Google Scholar 

9.

Bray DP, Quillin JW, Press RH et al (2021) Adjuvant radiotherapy versus watchful waiting for world health organization grade II atypical meningioma: a single-institution experience. Neurosurgery 88:E435–E442

PubMed  Google Scholar 

10.

Budohoski KP, Clerkin J, Millward CP et al (2018) Predictors of early progression of surgically treated atypical meningiomas. Acta Neurochir (Wien) 160:1813–1822

Google Scholar 

11.

Champeaux C, Dunn L (2016) World Health Organization Grade II meningioma: a 10-year retrospective study for recurrence and prognostic factor assessment. World Neurosurg 89:180–186

PubMed  Google Scholar 

12.

Champeaux C, Houston D, Dunn L (2017) Atypical meningioma. A study on recurrence and disease-specific survival. Neurochirurgie 63:273–281

CAS  PubMed  Google Scholar 

13.

Champeaux C, Wilson E, Shieff C et al (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neurooncol 129:337–345

PubMed  Google Scholar 

14.

Chen WC, Magill ST, Wu A et al (2018) Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. J Neurosurg 130:443–450

PubMed  Google Scholar 

15.

Chun SW, Kim KM, Kim MS et al (2021) Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis. Radiat Oncol 16:34

PubMed  PubMed Central  Google Scholar 

16.

Domingo RA, Tripathi S, Vivas-Buitrago T et al (2020) mitotic index and progression-free survival in atypical meningiomas. World Neurosurg 142:191–196

PubMed  Google Scholar 

17.

Drevon D, Fursa SR, Malcolm AL (2017) Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data. Behav Modif 41:323–339

PubMed  Google Scholar 

18.

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

CAS  PubMed  PubMed Central  Google Scholar 

19.

Fioravanzo A, Caffo M, Di Bonaventura R et al (2020) A risk score based on 5 clinico-pathological variables predicts recurrence of atypical meningiomas. J Neuropathol Exp Neurol 79:500–507

PubMed  Google Scholar 

20.

Fukushima S, Terasaki M, Sakata K et al (2009) Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol 26:51–57

PubMed  Google Scholar 

21.

Garcia-Segura ME, Erickson AW, Jairath R et al (2020) Necrosis and brain invasion predict radio-resistance and tumor recurrence in atypical meningioma: a retrospective cohort study. Neurosurgery 88:E42–E48

PubMed  Google Scholar 

22.

Hanft S, Canoll P, Bruce JN (2010) A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol 99:433–443

CAS  PubMed  Google Scholar 

23.

He L, Zhang B, Zhang J et al (2020) Effectiveness of postoperative adjuvant radiotherapy in atypical meningioma patients after gross total resection: a meta-analysis study. Front Oncol 10:556575

PubMed  Google Scholar 

24.

Jansen M, Mohapatra G, Betensky RA et al (2012) Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol Appl Neurobiol 38:213–219

CAS  PubMed  PubMed Central  Google Scholar 

25.

Karabagli P, Karabagli H, Mavi Z et al (2020) Histopathological and clinical features as prognostic factors of atypical meningiomas. Turk Neurosurg 30:746–575

PubMed  Google Scholar 

26.

Kim J, Kim KH, Kim YZ (2017) The clinical outcome of hydroxyurea chemotherapy after incomplete resection of atypical meningiomas. Brain Tumor Res Treat 5:77–86

PubMed  PubMed Central  Google Scholar 

27.

Kim MS, Kim KH, Lee EH et al (2014) Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. J Neurosurg 121:1189–1200

PubMed  Google Scholar 

28.

Kim SY, Park JE, Lee YJ et al (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408–414

PubMed  Google Scholar 

29.

Klinger DR, Flores BC, Lewis JJ et al (2015) Atypical meningiomas: recurrence, reoperation, and radiotherapy. World Neurosurg 84:839–845

PubMed  Google Scholar 

30.

Lee G, Lamba N, Niemierko A et al (2021) Adjuvant radiation therapy versus surveillance after surgical resection of atypical meningiomas. Int J Radiat Oncol Biol Phys 109:252–266

PubMed  Google Scholar 

31.

Lee KD, Depowell JJ, Air EL et al (2013) Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus 35:E15

PubMed  Google Scholar 

32.

Li H, Zhang YS, Zhang GB et al (2019) Treatment protocol, long-term follow-up, and predictors of mortality in 302 cases of atypical meningioma. World Neurosurg 122:e1275–e1284

PubMed  Google Scholar 

33.

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700

PubMed  PubMed Central  Google Scholar 

34.

Loewenstern J, Shuman W, Rutland JW et al (2019) Preoperative and histological predictors of recurrence and survival in atypical meningioma after initial gross total resection. World Neurosurg 128:e148–e156

PubMed  Google Scholar 

35.

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

Google Scholar 

36.

Morrison A, Polisena J, Husereau D et al (2012) The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care 28:138–144

Google Scholar 

37.

Nakasu S, Nakasu Y (2021) Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis. Brain Tumor Pathol 38:81–95

PubMed  Google Scholar 

38.

Olar A, Wani KM, Wilson CD et al (2017) Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol 133:431–444

CAS  PubMed  PubMed Central  Google Scholar 

39.

Perry A, Stafford SL, Scheithauer BW et al (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465

CAS  PubMed  Google Scholar 

40.

Rogers CL, Perry A, Pugh S et al (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol 18:565–574

PubMed  Google Scholar 

41.

Shakir SI, Souhami L, Petrecca K et al (2018) Prognostic factors for progression in atypical meningioma. J Neurosurg 129:1240–1248

PubMed  Google Scholar 

42.

Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

CAS  PubMed  PubMed Central  Google Scholar 

43.

Sun SQ, Cai C, Murphy RK et al (2014) Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery 75:356–363 (discussion 363)

PubMed  Google Scholar 

44.

Sun SQ, Kim AH, Cai C et al (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347–354 (discussion 354-345; quiz 355)

PubMed  Google Scholar 

45.

Tierney JF, Stewart LA, Ghersi D et al (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16

PubMed  PubMed Central  Google Scholar 

46.

Wang F, Xu D, Liu Y et al (2019) Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre. Acta Neurochir (Wien) 161:2563–2570

Google Scholar 

47.

Ye W, Ding-Zhong T, Xiao-Sheng Y et al (2020) Factors related to the post-operative recurrence of atypical meningiomas. Front Oncol 10:503

PubMed  PubMed Central  Google Scholar 

48.

Yoon H, Mehta MP, Perumal K et al (2015) Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. J Cancer Res Ther 11:59–66

PubMed  Google Scholar 

49.

Zima L, Baine MJ, Sleightholm R et al (2021) Pathologic characteristics associated with local recurrence of atypical meningiomas following surgical resection. J Clin Med Res 13:143–150

CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif